Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidylprolyl isomerase A pseudogene 82 (PPIAP82) is a presumed pseudogene related to peptidylprolyl isomerase A (PPIA), but it lacks scientific validation as a distinct genomic entity, functional gene, or therapeutic target. No canonical gene annotation, biological function, or disease association is reported. Research in the field focuses on other PPIA pseudogenes, such as PPIAP22, which regulate gene expression through RNA interactions and may play roles in cancer[2][4]. Pseudogenes can act as endogenous microRNA decoys or competitive endogenous RNAs, influencing the expression of their parent or related genes and impacting cellular processes like proliferation and immune modulation[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 82 (PPIAP82).